155 related articles for article (PubMed ID: 23526599)
1. The role of amyloid β in the pathogenesis of Alzheimer's disease.
Gilbert BJ
J Clin Pathol; 2013 May; 66(5):362-6. PubMed ID: 23526599
[TBL] [Abstract][Full Text] [Related]
2. Republished: the role of amyloid β in the pathogenesis of Alzheimer's disease.
Gilbert BJ
Postgrad Med J; 2014 Feb; 90(1060):113-7. PubMed ID: 24448248
[TBL] [Abstract][Full Text] [Related]
3. Synaptotoxic amyloid-β oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease?
Klein WL
J Alzheimers Dis; 2013; 33 Suppl 1():S49-65. PubMed ID: 22785404
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
5. Low-n oligomers as therapeutic targets of Alzheimer's disease.
Ono K; Yamada M
J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
[TBL] [Abstract][Full Text] [Related]
6. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers.
Decker H; Jürgensen S; Adrover MF; Brito-Moreira J; Bomfim TR; Klein WL; Epstein AL; De Felice FG; Jerusalinsky D; Ferreira ST
J Neurochem; 2010 Dec; 115(6):1520-9. PubMed ID: 20950339
[TBL] [Abstract][Full Text] [Related]
7. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of amyloid oligomers toxicity.
Kayed R; Lasagna-Reeves CA
J Alzheimers Dis; 2013; 33 Suppl 1():S67-78. PubMed ID: 22531422
[TBL] [Abstract][Full Text] [Related]
9. Fibrillar seeds alleviate amyloid-β cytotoxicity by omitting formation of higher-molecular-weight oligomers.
Wu WH; Liu Q; Sun X; Yu JS; Zhao DS; Yu YP; Luo JJ; Hu J; Yu ZW; Zhao YF; Li YM
Biochem Biophys Res Commun; 2013 Sep; 439(3):321-6. PubMed ID: 24012671
[TBL] [Abstract][Full Text] [Related]
10. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-β: the seeds of darkness.
Fodero-Tavoletti MT; Villemagne VL; Rowe CC; Masters CL; Barnham KJ; Cappai R
Int J Biochem Cell Biol; 2011 Sep; 43(9):1247-51. PubMed ID: 21601003
[TBL] [Abstract][Full Text] [Related]
12. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
[TBL] [Abstract][Full Text] [Related]
13. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
Tomiyama T
Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
[TBL] [Abstract][Full Text] [Related]
14. Curcuminoid binds to amyloid-β1-42 oligomer and fibril.
Yanagisawa D; Taguchi H; Yamamoto A; Shirai N; Hirao K; Tooyama I
J Alzheimers Dis; 2011; 24 Suppl 2():33-42. PubMed ID: 21335654
[TBL] [Abstract][Full Text] [Related]
15. Endogenous polyamines reduce the toxicity of soluble aβ peptide aggregates associated with Alzheimer's disease.
Luo J; Mohammed I; Wärmländer SK; Hiruma Y; Gräslund A; Abrahams JP
Biomacromolecules; 2014 Jun; 15(6):1985-91. PubMed ID: 24750033
[TBL] [Abstract][Full Text] [Related]
16. Biflavonoids are superior to monoflavonoids in inhibiting amyloid-β toxicity and fibrillogenesis via accumulation of nontoxic oligomer-like structures.
Thapa A; Woo ER; Chi EY; Sharoar MG; Jin HG; Shin SY; Park IS
Biochemistry; 2011 Apr; 50(13):2445-55. PubMed ID: 21322641
[TBL] [Abstract][Full Text] [Related]
17. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
[TBL] [Abstract][Full Text] [Related]
18. Deceleration of the neurodegenerative phenotype in pyroglutamate-Aβ accumulating transgenic mice by oral treatment with the Aβ oligomer eliminating compound RD2.
Schemmert S; Schartmann E; Honold D; Zafiu C; Ziehm T; Langen KJ; Shah NJ; Kutzsche J; Willuweit A; Willbold D
Neurobiol Dis; 2019 Apr; 124():36-45. PubMed ID: 30391539
[TBL] [Abstract][Full Text] [Related]
19. [The role of zinc ions and structural polymorphism of β-amyloid in the Alzheimer's disease initiation].
Kulikova AA; Makarov AA; Kozin SA
Mol Biol (Mosk); 2015; 49(2):249-63. PubMed ID: 26065253
[TBL] [Abstract][Full Text] [Related]
20. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
